![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
GE Schwab, JL Raucy and EF Johnson
Department of Basic and Clinical Research, Research Institute of Scripps Clinic, La Jolla, California 92037.
Rifampicin induces cytochrome P-450 3c, progesterone 16 alpha- and 6 beta-hydroxylation, 17 beta-estradiol 2-hydroxylation, benzo[a] pyrene hydroxylation, and erythromycin N-demethylation in rabbit liver microsomes. Kinetic analysis of the 6 beta-hydroxylation of progesterone as catalyzed by liver microsomes prepared from rifampicin- treated B/J rabbits exhibits a curvilinear double-reciprocal plot, suggestive of substrate activation. Further experimentation demonstrated that alpha-naphthoflavone could augment the catalytic efficiency [Vmax/Km] observed for the 16 alpha- and 6 beta- hydroxylation of progesterone and the 2-hydroxylation of 17 beta- estradiol, whereas erythromycin N-demethylase activity was partially inhibited. Allosteric activation of these steroid hydroxylases by alpha- naphthoflavone is also found for human liver microsomes, indicating that the activation of these enzymes is conserved in man and rabbit.
This article has been cited by other articles:
|
|
 |
|
  C. D. Sohl, E. M. Isin, R. L. Eoff, G. A. Marsch, D. F. Stec, and F. P. Guengerich Cooperativity in Oxidation Reactions Catalyzed by Cytochrome P450 1A2: HIGHLY COOPERATIVE PYRENE HYDROXYLATION AND MULTIPHASIC KINETICS OF LIGAND BINDING J. Biol. Chem., March 14, 2008; 283(11): 7293 - 7308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-i. Fujita, Y. Ando, M. Narabayashi, T. Miya, F. Nagashima, W. Yamamoto, K. Kodama, K. Araki, H. Endo, and Y. Sasaki GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN Drug Metab. Dispos., December 1, 2005; 33(12): 1785 - 1790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Vuppugalla and R. Mehvar ENZYME-SELECTIVE EFFECTS OF NITRIC OXIDE ON AFFINITY AND MAXIMUM VELOCITY OF VARIOUS RAT CYTOCHROMES P450 Drug Metab. Dispos., June 1, 2005; 33(6): 829 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Williams, J. Cosme, D. M. Vinkovic, A. Ward, H. C. Angove, P. J. Day, C. Vonrhein, I. J. Tickle, and H. Jhoti Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone Science, July 30, 2004; 305(5684): 683 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Khan, H. Liu, and J. R. Halpert Homotropic Versus Heterotopic Cooperativity of Cytochrome P450eryF: A Substrate Oxidation and Spectral Titration Study Drug Metab. Dispos., April 1, 2003; 31(4): 356 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nakamura, N. Torimoto, I. Ishii, N. Ariyoshi, H. Nakasa, S. Ohmori, and M. Kitada CYP3A4 and CYP3A7-Mediated Carbamazepine 10,11-Epoxidation Are Activated by Differential Endogenous Steroids Drug Metab. Dispos., April 1, 2003; 31(4): 432 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hutzler, D. Kolwankar, M. A. Hummel, and T. S. Tracy Activation of CYP2C9-Mediated Metabolism by a Series of Dapsone Analogs: Kinetics and Structural Requirements Drug Metab. Dispos., November 1, 2002; 30(11): 1194 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nakamura, H. Nakasa, I. Ishii, N. Ariyoshi, T. Igarashi, S. Ohmori, and M. Kitada Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes Drug Metab. Dispos., May 1, 2002; 30(5): 534 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hutzler and T. S. Tracy Atypical Kinetic Profiles in Drug Metabolism Reactions Drug Metab. Dispos., April 1, 2002; 30(4): 355 - 362. [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Khan, Y. Q. He, T. L. Domanski, and J. R. Halpert Midazolam Oxidation by Cytochrome P450 3A4 and Active-Site Mutants: an Evaluation of Multiple Binding Sites and of the Metabolic Pathway That Leads to Enzyme Inactivation Mol. Pharmacol., March 1, 2002; 61(3): 495 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Kenworthy, S. E. Clarke, J. Andrews, and J. B. Houston Multisite Kinetic Models for CYP3A4: Simultaneous Activation and Inhibition of Diazepam and Testosterone Metabolism Drug Metab. Dispos., December 1, 2001; 29(12): 1644 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hutzler, M. J. Hauer, and T. S. Tracy Dapsone Activation of CYP2C9-Mediated Metabolism: Evidence for Activation of Multiple Substrates and a Two-Site Model Drug Metab. Dispos., July 1, 2001; 29(7): 1029 - 1034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Stresser, A. P. Blanchard, S. D. Turner, J. C. L. Erve, A. A. Dandeneau, V. P. Miller, and C. L. Crespi Substrate-Dependent Modulation of CYP3A4 Catalytic Activity: Analysis of 27 Test Compounds with Four Fluorometric Substrates Drug Metab. Dispos., April 13, 2001; 28(12): 1440 - 1448. [Abstract] [Full Text]
|
|
|
|
|
|
M. L. Schrag and L. C. Wienkers Triazolam Substrate Inhibition: Evidence of Competition for Heme-Bound Reactive Oxygen Within the CYP3A4 Active Site Drug Metab. Dispos., January 1, 2001; 29(1): 70 - 75. [Abstract] [Full Text]
|
|
|
|
 |
|
 I. Stupans, G. Stretch, and P. Hayball Olive Oil Phenols Inhibit Human Hepatic Microsomal Activity J. Nutr., September 1, 2000; 130(9): 2367 - 2370. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. L. Domanski, Y.-A. He, G. R. Harlow, and J. R. Halpert Dual Role of Human Cytochrome P450 3A4 Residue Phe-304 in Substrate Specificity and Cooperativity J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 585 - 591. [Abstract] [Full Text]
|
|
|
|
|
|
J. B. Houston and K. E. Kenworthy In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model Drug Metab. Dispos., March 1, 2000; 28(3): 246 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Äbelö, T. B. Andersson, U. Bredberg, I. Skånberg, and L. Weidolf Stereoselective Metabolism by Human Liver CYP Enzymes of A Substituted Benzimidazole Drug Metab. Dispos., January 1, 2000; 28(1): 58 - 64. [Abstract] [Full Text]
|
|
|
|
|
|
J. C. Stevens, T. L. Domanski, G. R. Harlow, R. B. White, E. Orton, and J. R. Halpert Use of the Steroid Derivative RPR 106541 in Combination with Site-Directed Mutagenesis for Enhanced Cytochrome P-450 3A4 Structure/Function Analysis J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 594 - 602. [Abstract] [Full Text]
|
|
|
|
|
|
E. Ludwig, J. Schmid, K. Beschke, and T. Ebner Activation of Human Cytochrome P-450 3A4-Catalyzed Meloxicam 5'-Methylhydroxylation by Quinidine and Hydroquinidine In Vitro J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 1 - 8. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Halpert, T. L. Domanski, O. Adali, C. P. Biagini, J. Cosme, E. A. Dierks, E. F. Johnson, J. P. Jones, P. O. de Montellano, R. M. Philpot, et al. Structure-Function of Cytochromes P450 and Flavin-Containing Monooxygenases. Implications for Drug Metabolism Drug Metab. Dispos., December 1, 1998; 26(12): 1223 - 1231. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Machinist, M. D. Mayer, E. M. Roberts, B. W. Surber, and A. D. Rodrigues Identification of the Human Liver Cytochrome P450 Enzymes Involved in the In Vitro Metabolism of a Novel 5-Lipoxygenase Inhibitor Drug Metab. Dispos., October 1, 1998; 26(10): 970 - 976. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Fayz and T. Inaba Zidovudine Azido-Reductase in Human Liver Microsomes: Activation by Ethacrynic Acid, Dipyridamole, and Indomethacin and Inhibition by Human Immunodeficiency Virus Protease Inhibitors Antimicrob. Agents Chemother., July 1, 1998; 42(7): 1654 - 1658. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. R. Harlow and J. R. Halpert Analysis of human cytochrome P450 3A4 cooperativity: Construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics PNAS, June 9, 1998; 95(12): 6636 - 6641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bylund, T. Kunz, K. Valmsen, and E. H. Oliw Cytochromes P450 with Bisallylic Hydroxylation Activity on Arachidonic and Linoleic Acids Studied with Human Recombinant Enzymes and with Human and Rat Liver Microsomes J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 51 - 60. [Abstract] [Full Text]
|
|
|
|
|
|
G. R. Harlow and J. R. Halpert Alanine-scanning Mutagenesis of a Putative Substrate Recognition Site in Human Cytochrome P450 3A4. ROLE OF RESIDUES 210AND 211IN FLAVONOID ACTIVATION AND SUBSTRATE SPECIFICITY J. Biol. Chem., February 28, 1997; 272(9): 5396 - 5402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Fitzsimmons and J. M. Collins Selective Biotransformation of the Human Immunodeficiency Virus Protease Inhibitor Saquinavir by Human Small-Intestinal Cytochrome P4503A4. Potential Contribution to High First-Pass Metabolism Drug Metab. Dispos., February 1, 1997; 25(2): 256 - 266. [Abstract] [Full Text]
|
|
|
|
|
|
A. P. Koley, J. T. M. Buters, R. C. Robinson, A. Markowitz, and F. K. Friedman CO Binding Kinetics of Human Cytochrome P450 3A4 J. Biol. Chem., March 10, 1995; 270(10): 5014 - 5018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xiang, R. A. Tschirret-Guth, and P. R. Ortiz de Montellano An A245T Mutation Conveys on Cytochrome P450eryF the Ability to Oxidize Alternative Substrates J. Biol. Chem., November 10, 2000; 275(46): 35999 - 36006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cupp-Vickery, R. Anderson, and Z. Hatziris Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity PNAS, March 28, 2000; 97(7): 3050 - 3055. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
